Community Intervention to Improve Depressive Symptoms Among Older Adults (VIDACTIVA) (VIDACTIVA1)

October 28, 2023 updated by: Universidad de San Martín de Porres

Pilot Trial of an Evidence-based Community Intervention to Improve Depressive Symptoms Among Peruvian Older Adults

The goal of this pilot trial is to test how feasible is to conduct a large clinical trial that evaluate both implementation and effectiveness outcomes of a community-based interventions for older adults with depression in low-resource urban settings from Lima, Peru.

The main questions:

Is the way we are planning the study, including those who are taking part and what they will do, good for a large study?

Is the interventional package we are developing good the way it is, and can it be done the way we planned it?

Study Overview

Status

Recruiting

Conditions

Detailed Description

Participants who join will be split into two groups: one group will get the interventional program, and the other group will get standard care. In the interventional group, community health workers will meet with participants eight times to do activities and talk about how they feel. The standard group will have two visits where they will learn things about mental health.

The results of the study will help the researchers understand whether they can test the program in larger study. Additionally, see whether those participants in the interventional group feel better than those who are in the standard group.

Sample size: This is a pilot trial. No sample size calculations are needed because the objective is NOT to evaluate the effect of the intervention, but rather the feasibility of conducting a large-scale clinical trial. It is expected to enroll 64 participants (32 control group vs 32 intervention group). This number is based on previous formative study and training of community health workers.

Researchers will collect basic information to assess feasibility for a larger trial, including:

  • Number of potential participants screened per month;
  • Number of participants enroled per month;
  • Average time from enrolment to randomisation.
  • Average time to reach enrolment goal
  • Proportion of eligible participants who enrol
  • Proportion of people who maintain the study in both groups.
  • Reasons for abandoning the study.
  • Visit durations

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Oscar Flores-Flores, MD, MSc
  • Phone Number: +51934901717
  • Email: ofloresf@usmp.pe

Study Contact Backup

Study Locations

      • Lima, Peru
        • Recruiting
        • Universidad de San Martin de Porres
        • Contact:
          • Vanessa Patiño, BA
        • Sub-Investigator:
          • Diego Otero-Oyague

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having depressive symptoms (score equal to or greater than 6 on the Patient Health Questionnaire - PHQ 9).
  • Capacity to give consent.
  • Current residence in Villa El Salvador, Lima, Peru.

Exclusion Criteria:

  • Previous diagnosis of bipolar disorder
  • History of substance abuse
  • History of dissociative disorder, psychosis or dementia, or moderate memory and/or cognition problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
VIDACTIVA program

Community health workers (CHWs) will delivered VIDACTIVA intervention that consists in 8 home-sessions, one hour duration, within a period of 14 weeks + 2 follow-up calls (monthly). In total, a period of 22 weeks.

The multicomponent intervention consist in the following:

Problem-Solving Exercises: These are basic structured exercises aimed at training older individuals in problem-solving. This activity is centered around the older adult, meaning the older adults guides this activity, and the CHWs is a facilitator.

Physical Activation: This component involves planning and "scheduling" enjoyable activities (physical or social) that the older adult chooses based on their preferences and capabilities.

Education on Depressive Symptoms (psychoeducation)

Active Comparator: Control group
Standard Care
Study fieldworkers will provide 2 educational sessions (45-60 min) about mental health at old age and participant will be guided to mental health community services (primary care centers). One session after the enrolment (week 1) and one at the 14th week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms
Time Frame: At baseline, at 14th and 22th week.
Measured by Patient Health Questionnaire - 9 (PHQ-9) [ minimum score: 0 ; maximum score: 27 ] [More score = worse symptoms]
At baseline, at 14th and 22th week.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety symptoms
Time Frame: At baseline, at 14th and 22th week.
Measured by Generalised Anxiety Disorder - 7 (GAD-7) [min score: 0 , max score: 21] [more score, worse symptoms]
At baseline, at 14th and 22th week.
Loneliness
Time Frame: At baseline, at 14th and 22th week.
Measured by the Three-Items Loneliness [min 0, max: 9] [more score, more lonely]
At baseline, at 14th and 22th week.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Oscar Flores-Flores, MD, MSc, Universidad de San Martin de Porres

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2023

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

September 26, 2023

First Submitted That Met QC Criteria

October 2, 2023

First Posted (Actual)

October 3, 2023

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 28, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E10012021018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Once first manuscript using data is published.

IPD Sharing Time Frame

Expected to be available, once first manuscript is published. Expected 2025. For the next five years (2030).

IPD Sharing Access Criteria

We will share data based on reasonable request of a researcher.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Anxiety

Clinical Trials on VIDACTIVA sessions

3
Subscribe